Saami Yazdani

Latest news from the SKY BioFLuids laboratory ( providing information on cardiovascular disease and prevention.

[Wake Forest Biomedical Engineering @WakeBME]

🎉Congratulation to @lindabliu for receiving the 2024 ASDIN Research in Vascular Access Grant! Her research will continue in the @biofluids_org lab under faculty advisor, Dr. Saami Yazdani🥳
Read more about her research here👉https://t.co/9A0FZfsNeX
#GrantAward #ASDIN @ASDINNews

[𝗖𝗼𝗿𝗱𝗶𝘀 @cordis]

BIG #ANNOUNCEMENT! We’re excited to announce our acquisition of @MedallianceSA, a Switzerland-based medical technology company pioneering key innovations for coronary and peripheral arterial disease. More information below! #Cordis #FreetoImagine https://t.co/9N9vLwEaaW

[Saami Yazdani @biofluids_org]

Surmodics’ Sundance #drugcoatedballoon #DCB Evaluated in SWING BTK First-in-Human Trial on @EVToday https://t.co/4KX69kO0Vh

[Saami Yazdani @biofluids_org]

Advanced NanoTherapies' SirPlux Duo #DrugCoatedBalloon Receives FDA Breakthrough Designation for Small Vessel Coronary Artery Disease https://t.co/ofocE9xo9v

[Saami Yazdani @biofluids_org]

Excited to share our latest review paper on liquid drug delivery devices with authors Meagan Todd, Dr. Pradeep Nair @CardioInstitute, Dr. Jacques Ohayon and Dr. Roderic Pettigrew @TAMUHealth .
https://t.co/wp73iQC6Yc

[Saami Yazdani @biofluids_org]

Our latest collaborative work on RNA Aptamers for treatment of occlusive cardiovascular disease.
https://t.co/VEqXrkildp

[Saami Yazdani @biofluids_org]

BD Launches PREVISION FIH Trial of a Peripheral Sirolimus DCB on @EVToday #drugcoatedballoon https://t.co/wQp8G8XuaP

[Saami Yazdani @biofluids_org]

Out today is our latest work on the mechanism of DCBs #drugcoatedballoon

Published at
https://t.co/J0QQldMdCW

[Saami Yazdani @biofluids_org]

And another congratulations to Linda for winning the 2nd place open presentation competition at #VASA2022 (notified today)

[Saami Yazdani @biofluids_org]

Congrats Linda for her first podium talk at #VASA2022

[Saami Yazdani @biofluids_org]

Always something to learn and gain at #NCVH2022

[Saami Yazdani @biofluids_org]

Speaker: Time to ‘move on’ from mortality-related concerns of paclitaxel-coated devices https://t.co/ld4ZipEV0a

[Endovascular Today @EVToday]

MedAlliance Acquires MDK Medical | @MedallianceSA
https://t.co/WgP6LYqBnM

[Saami Yazdani @biofluids_org]

CSI announces FIH experience with coronary everolimus #drugcoatedballoon
https://t.co/UpDzR7nlWR

[Saami Yazdani @biofluids_org]

Latest meta-analysis on paclitaxel in peripheral arterial disease provokes mixed reception | Vascular News #drugcoatedballoon
https://t.co/4GDJKsWuiF

[Saami Yazdani @biofluids_org]

#NCVH2021
Great to be back!

[Saami Yazdani @biofluids_org]

Abbott’s Xience Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy for High Bleeding Risk Patients https://t.co/tzQcJKkLW0

[Saami Yazdani @biofluids_org]

Reading: Boston Scientific initiates coronary #drugcoatedballoon study in U.S. https://t.co/DwWYxGDogO @medicaltubing

[Saami Yazdani @biofluids_org]

IN.PACT AV #Drugcoatedballoon is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating AV Fistulae Lesions https://t.co/5c0LAGtUDd

[Saami Yazdani @biofluids_org]

Medtronic Japan Launches the First #Drugcoatedballoon in Japan, IN.PACT AV DCB, for Patients Undergoing Hemodialysis https://t.co/jiH9nDXVi5